The Indian regulatory authority has shut down 36 percent of manufacturing units of substandard tested drugs, reported 24NewsHD TV channel on Tuesday.
According to report, the regulatory authority has shut down more than 36 percent of the 400 drug manufacturing units since last year.
The units were closed due to continuous complaints of substandard medicines.
Medicines manufactured by Haryana-based Maiden Pharmaceuticals, Noida and Punjab-based QP Pharmachem were declared contaminated by the WHO.
Children's cough syrup deaths in Gambia, Uzbekistan and Cameroon were linked to medicines made by Indian pharma firm Maiden Pharmaceuticals.
India's Central Drug Standard Control Organization chief Rajiv Raghuvanshi said that
"The quality of Indian pharma industry has gone down a lot due to the manufacturing of substandard medicines."
Lack of proper documentation, drug verification process and fully equipped quality control laboratories has hampered the quality management system, says Rajeev Raghuvanshi.
Cough syrups made in India have caused the death of more than 300 children worldwide.
The drugs were found to contain high levels of two known toxic chemicals, diethylene glycol and ethylene glycol, which caused severe kidney damage and death.
India is also among the third largest drug producing countries in the world.
Indian pharmaceutical companies have also become globally infamous.
In the past, many children died in Africa after drinking Indian cough syrup because of the high concentration of ethylene glycol in the syrup.
In the past, the US had stopped the import of mangoes from India after pesticides were found in Indian mangoes.
Since Modi came to power, almost every institution in India has become a bastion of irresponsibility and corruption.
Modi is busy touting his strong economy to the world while every day some report reveals a new side of India's sinking economy.
Reporter: Ahmad Mansoor